Acquisition - September 25, 2020
LEO Pharma sells portfolio of four products to Cheplapharm
LEO Pharma has announced the sale of a portfolio of four non-core products to Cheplapharm for EUR 300 million. The agreement represents a milestone in the roll-out of LEO Pharma’s 2030 strategy which increases the company’s focus on new innovative solutions for medical dermatology, it states. Read more: LEO Pharma’s 2030 strategy might to lead […]
Careers article - September 15, 2020
LEO Pharma’s 2030 strategy might to lead to reduction of staff
At the end of August, LEO Pharma announced that it will accelerate its R&D efforts and diversify its portfolio of medicines to cover a range of dermatological indications including rare diseases. The company is aiming to launch a new innovative treatment every 2-3 years, it states. “Building on our strong legacy and deep understanding of […]
Pharma Business - September 2, 2019
LEO Pharma files IND application to FDA
LEO Pharma and Korean JW Pharmaceutical have announced that LEO Pharma has filed an Investigational New Drug Application (IND) to the US Food and Drug Administration (FDA) for a pharmacokinetics study in the US. The filing is based on the two companies’ ongoing collaboration on the development of JW1601/LP0190, an oral treatment for atopic dermatitis […]
In a new job - June 12, 2019
LEO Pharma appoints new CEO
Gitte Aabo will step down as President and CEO after 27 years in the company, and 11 of these as CEO, and the Board of Directors has appointed Catherine Mazzacco as new President and CEO effective August 1, 2019. A joint decision LEO Pharma has embarked on a strategy towards 2025 and has during recent […]
Profiles in Business - May 15, 2019
Gitte Aabo – A true pharmaceutical industry leader
She joined LEO Pharma by chance, more than 27 years ago, but she remained there, for the true focus on helping patients and her love of the job. For more than a century Denmark’s LEO Pharma has had a solid niche, creating and selling drugs for dermatological and thrombotic conditions, penetrating markets across the world. […]
In a new job - May 13, 2019
LEO Pharma strengthens its global development team
The company has appointed Beth-Anne Lang as Vice President and Head of Global Regulatory Affairs and Christine Garrett as Vice President and Head of Global Project Management. Both will join LEO Pharma on May 13. Based in New Jersey Beth-Anne Lang and Christine Garrett will be based in Madison, New Jersey and be part of […]
